Asia On The Move: New CFDA Directors, AZ China GM
This article was originally published in PharmAsia News
Executive Summary
The China FDA has appointed several key directors and UK drug maker AstraZeneca has quietly changed its China head to a locally grown executive. Personnel changes also take place in major domestic maker Hisun, the China State Administration for Industry and Commerce (SAIC), Acucela and AdvaMed.